Skip to content

Ayahuasca: all studies

Page 4 of 167: studies 31 to 40 of 1,663, newest first. Back to the ayahuasca overview

Research

Beyond Enthusiasm: Ayahuasca and the Future of Depression Research.

Revista Brasileira de Psiquiatria July 7, 2026 Alberto Souza Sá Filho, James Oluwagbamigbe Fajemiroye, Antonio Egidio Nardi et al.

Few topics in contemporary psychiatry generate as much fascination, hope, and discomfort as the therapeutic use of psychedelics.For some, they represent a long-awaited disruption in the treatment of depression, a field in which many patients still experience partial response, relapse, or treatment resistance despite decades of

Effects of an international ceremonial ayahuasca retreat on the diversity and community composition of the human gut microbiome: A preliminary observational single-arm pre-post study

Brain Behavior and Immunity Integrative July 1, 2026 Lyanna R. Kessler, Lamya'a Dawud, John D. Sterrett et al.

ABSTRACT Posttraumatic stress disorder (PTSD) is a mental health condition that can develop following exposure to a traumatic event, often with persistent anxiety and depressive symptoms. Recent research suggests the microbiome-gut-brain axis may play an important role in the etiology and pathophysiology of PTSD. At the same time, retreats incorporating psychedelic-assisted therapies have...

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review.

Clinical Pharmacology & Therapeutics July 1, 2026 Tijana Stojanovic, Kent W Nilsson, Robert Fredriksson et al.

Interest in ayahuasca and its main component, N,N-Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited. We therefore systematically examined registered interventional trials of DMT, ayahuasca, and DMT combined with...

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 2026 Guilherme Lodetti, Rafael Mariano de Bitencourt, Antonio Inserra et al.

BackgroundAlcohol use disorder (AUD) remains difficult to treat with lasting success, leading to growing interest in alternative therapeutic approaches. Psychedelic compounds such as Ayahuasca, a traditional brew used in Indigenous Amazonian ceremonies containing N,N-dimethyltryptamine (DMT) along with monoamine oxidase-inhibiting β-carbolines, have shown promise in reducing addictive...

DOI: 10.1016/j.pnpbp.2026.111817 (opens in new tab) Ayahuasca Serotonin Oxidative stress Glutathione peroxidase +12

EXPANSÃO GLOBAL DA AYAHUASCA E SAÚDE MENTAL

Interações - cultura e comunidade June 23, 2026 Leonardo Tondato Mello, Kemily Bakri Ottoni, Janaína Liz Aquino

Este artigo reflete sobre a expansão global da Ayahuasca e suas implicações para a redução de danos em saúde mental e para as transformações na psique individual e coletiva. Tem como objetivo analisar os potenciais psicoterapêuticos e os desafios psicossociais do uso da Ayahuasca por pessoas não indígenas formadas sob pilares antropocêntricos. Para isso, realizou-se uma revisão bibliográfica a...

DOI: 10.5752/p.1983-2478.2026v21n1e211d04 (opens in new tab) Ayahuasca Context archaeology Mental health Perspective graphical +2

Global pressure on ayahuasca threatens Amazonian plants and knowledge systems

June 23, 2026 Carlos Minuano

“One of the world’s largest pharmacies is being destroyed,” says Benki Piyãko, a leader of the Ashaninka Indigenous people in the Brazilian state of Acre. The warning points to multiple threats advancing on the Amazon but also to growing debate surrounding one of the so-called forest medicines: ayahuasca. This Indigenous beverage with psychedelic properties is […]

DOI: 10.66709/news-321692 (opens in new tab) Ayahuasca Amazon rainforest Indigenous Traditional knowledge +8

Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World

June 21, 2026 Jonathan David, Aviva Berkovich-Ohana, Yair Dor-Ziderman et al. preprint

Background: Despite the rapid growth of psychedelic research, limited attention has been given to how psychedelics are used, experienced and integrated within highly conservative religious communities, and in Jewish contexts more broadly. This study addresses this gap by examining ayahuasca use among the ultra-Orthodox (Haredi) community, a highly religious, conservative, and collectivist...

Brain-body integromics of the ayahuasca experience.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie June 1, 2026 Francisco Madrid-Gambin, Pablo Mallaroni, Noemí Haro et al.

Ayahuasca is a psychoactive brew containing N,N-dimethyltryptamine (DMT) and β-carboline alkaloids that induces marked alterations in perception, emotion and self-referential processing. However, the multiscale biological organization linking peripheral metabolism, brain network dynamics, neurochemistry, and subjective experience in humans remains poorly understood. Here, we applied an...

An exploratory persistent-homology analysis of resting-state fMRI functional connectivity under Ayahuasca

Chaos Solitons & Fractals May 30, 2026 Tales Ramos Monteiro Dos Santos, Draulio B Araujo, Helcio Felippe et al.

Psychedelic states offer a useful setting for studying changes in large-scale brain organization. Here, we applied Topological Data Analysis (TDA) to resting-state fMRI functional connectivity from nine participants scanned before and after Ayahuasca ingestion. Vietoris–Rips filtrations were constructed from correlation-derived dissimilarity matrices, and persistent entropy was used to quantify...

DOI: 10.1016/j.chaos.2026.118554 (opens in new tab) Ayahuasca Functional connectivity Exploratory analysis Resting State FMRI +3

Phytochemical and Neuropharmacological Evaluation of Banisteriopsis caapi, Paullinia cupana, and Turnera diffusa for Potential Anti-Addiction Activity

Journal of Advances in Medicine and Pharmaceutical Sciences May 24, 2026 Fernando Benevenuto, Iscia Martha Franco, Antonio Eizirik et al.

Addiction remains a major neuropsychiatric challenge, with dopaminergic, serotonergic, and GABAergic dysregulation underlying maladaptive behaviors. Traditional Brazilian medicinal plants offer a rich source of neuroactive compounds, yet their multi-target mechanisms remain underexplored. This study aimed to evaluate the neuropharmacological potential of harmine, caffeine, and damianin through...

DOI: 10.36079/lamintang.jamaps-0501.935 (opens in new tab) Phytochemical Allosteric modulator In silico Docking animal +6